We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About ENTvantageDX Stock

Invest in or calculate the value of your shares in ENTvantageDX or other pre-IPO companies through EquityZen's platform.

Get Started

ENTvantageDX Stock (ENDX)

ENTvantage Diagnostics is a medical diagnostics company that develops and markets in-office diagnostic tests.

About ENTvantageDX Stock

Founded

2013

Headquarters

Austin, TX, US

Industries

Software, Artificial Intelligence, Data and Analytics

ENTvantage Diagnostics is a medical diagnostics company that develops and markets in-office diagnostic tests that provide primary care and ENT physicians with timely information on the causes of ear, nose, and throat illnesses. Its diagnostic test kit can qualitatively identify the three major bacterial sinusitis pathogens and provide differentiation from viral sinusitis infections that enables physicians to only prescribe antibiotic treatment for patients who have bacterial sinusitis, reducing unnecessary prescription of antibiotics. Its products include Sinu-Now Collection Device that allows physicians and nurses to collect mucus samples from the middle meatus region of the sinus; and BacDtect-3 Assay that allows physicians to test sinusitis patients to determine if the patients’ symptoms are caused by bacterial pathogens and or the more common viral cause. ENTvantage Diagnostics was founded in 2014 and is based in Austin, Texas.

ENTvantageDX Management

Leadership team at ENTvantageDX

President & CEO

Joe Skraba

Scientific Advisory Board

Amber Luong

Locked Features

Join now and verify your accreditation status to gain access to:

  • ENTvantageDX current valuation
  • ENTvantageDX stock price
  • Available deals in ENTvantageDX and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in ENTvantageDX stock?

Accredited investors can buy pre-IPO stock in companies like ENTvantageDX through EquityZen funds. These investments are made available by existing ENTvantageDX shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell ENTvantageDX stock?

Shareholders can sell their ENTvantageDX stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."